Ajanta Pharma succeeds in revoking Allergan Patents

12 Aug 2013 Evaluate

Ajanta Pharma, a specialty focused pharmaceutical formulation company, has emerged successful in revoking two composition patents of Allergan Inc. The company had applied for revocation of both the patents under independent applications in 2011 on grounds of obviousness, not an invention, not patentable, insufficiency and non-disclosure under Section 8 of the Patents Act (2005) with Intellectual Property Appellate Board (IPAB). The combination patent decision has emerged as a landmark decision at IPAB.

Both the patents were on medicines for eye-related treatments and were granted by the Kolkata Patent Office in December 2007 and May 2008 respectively.

Ajanta Pharma is engaged manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×